QIAGEN NV (QGEN)
54.37
-1.08
(-1.95%)
USD |
NYSE |
Jan 21, 12:27
QIAGEN Price: 54.37 for Jan. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InflaRx NV | 0.985 |
| CDT Equity, Inc. | 1.40 |
| LENZ Therapeutics, Inc. | 19.66 |
| Liminatus Pharma, Inc. | 0.719 |
| Oruka Therapeutics, Inc. | 33.76 |
Price Related Metrics
| PE Ratio | 27.86 |
| PS Ratio | 5.455 |
| PEG Ratio | 0.0728 |
| Price to Book Value | 3.069 |
| Price to Free Cash Flow | 23.91 |
| Earnings Yield | 3.59% |
| Market Cap | 11.20B |
| PEGY Ratio | 0.0714 |
| Operating PE Ratio | 20.76 |
| Normalized PE Ratio | 25.07 |